CIX

Scispot Joins Ontario Genomics' BioCreate Program to Enhance Ontario's Role on the Global Biomanufacturing Stage

Retrieved on: 
Friday, April 5, 2024

KITCHENER, ON, April 5, 2024 /PRNewswire-PRWeb/ -- Scispot, the leading tech stack for biotech, announced its selection into the BioCreate Program by Ontario Genomics. This selection underscores its innovative efforts in creating AI-powered digital infrastructure to bolster the bioeconomy in Canada and worldwide.

Key Points: 
  • KITCHENER, ON, April 5, 2024 /PRNewswire-PRWeb/ -- Scispot , the leading tech stack for biotech, announced its selection into the BioCreate Program by Ontario Genomics.
  • This selection underscores its innovative efforts in creating AI-powered digital infrastructure to bolster the bioeconomy in Canada and worldwide.
  • "Being selected for the BioCreate program is a privilege, allowing us to contribute to Ontario's expanding biotech influence.
  • For more information about Scispot's role in transforming the biotech sector, visit Scispot

CI Financial Corp. Announces Final Results of Substantial Issuer Bid

Retrieved on: 
Friday, April 5, 2024

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) today announced the final results of its substantial issuer bid (the “Offer”) under which it has purchased for cancellation 4,857,142 of its common shares (the “Shares”) at the purchase price of $17.50 per Share, for an aggregate purchase price of approximately $85 million.

Key Points: 
  • CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) today announced the final results of its substantial issuer bid (the “Offer”) under which it has purchased for cancellation 4,857,142 of its common shares (the “Shares”) at the purchase price of $17.50 per Share, for an aggregate purchase price of approximately $85 million.
  • Shares purchased under the Offer represent approximately 3.11% of the issued and outstanding Shares at the time that the Offer was commenced.
  • Based on the final count by Computershare Investor Services Inc., the depositary for the Offer (the “Depositary”), a total of 12,586,530 Shares were properly tendered and not withdrawn.
  • To assist shareholders in determining the Canadian tax consequences of the Offer, CI Financial estimates that for the purposes of the Income Tax Act (Canada), the paid-up capital per Share is approximately $10.7284.

CI Financial Announces Approval of Proposed Amendments at Debentureholder Meetings

Retrieved on: 
Thursday, April 4, 2024

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has successfully obtained approval of certain previously announced amendments (the “Proposed Amendments”) from (i) holders (the “2025 Debentureholders”) of its 3.759% Debentures due 2025 (the “2025 Debentures”) issued under the second supplemental indenture (the “2019 Second Series Supplement”) to the trust indenture dated as of July 22, 2019, and (ii) holders (the “2027 Debentureholders”) of its 3.904% Debentures due 2027 (the “2027 Debentures”) issued under the sixth supplemental indenture (the “2009 Sixth Series Supplement”) to the trust indenture dated as of December 16, 2009.

Key Points: 
  • CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has successfully obtained approval of certain previously announced amendments (the “Proposed Amendments”) from (i) holders (the “2025 Debentureholders”) of its 3.759% Debentures due 2025 (the “2025 Debentures”) issued under the second supplemental indenture (the “2019 Second Series Supplement”) to the trust indenture dated as of July 22, 2019, and (ii) holders (the “2027 Debentureholders”) of its 3.904% Debentures due 2027 (the “2027 Debentures”) issued under the sixth supplemental indenture (the “2009 Sixth Series Supplement”) to the trust indenture dated as of December 16, 2009.
  • The Proposed Amendments are further described in the Joint Consent and Proxy Solicitation Statement dated March 6, 2024, available on CI Financial’s SEDAR+ profile at www.sedarplus.com .
  • The Proposed Amendment to the 2019 Second Series Supplement was approved at a meeting of 2025 Debentureholders and the Proposed Amendment to the 2009 Sixth Series Supplement was approved at a meeting of 2027 Debentureholders.
  • Detailed voting results are as follows:
    C$52,037,000 principal amount of 2025 Debentures representing 68.26% of the aggregate principal amount outstanding submitted voting instructions.

CI Financial Corp. Announces Preliminary Results of Substantial Issuer Bid

Retrieved on: 
Wednesday, April 3, 2024

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) today announced the preliminary results of its substantial issuer bid (the “Offer”), which expired at 5:00 p.m. (Toronto Time) on April 2, 2024.

Key Points: 
  • CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) today announced the preliminary results of its substantial issuer bid (the “Offer”), which expired at 5:00 p.m. (Toronto Time) on April 2, 2024.
  • In accordance with the terms of the Offer, CI Financial has informed the Depositary that it is taking up Shares properly tendered to the Offer at the time of expiry, subject to proration (as described below).
  • Based on the preliminary count by the Depositary, CI Financial expects to take up and purchase for cancellation 4,857,142 Shares at the purchase price of $17.50 per Share for an aggregate purchase price of approximately $85 million.
  • Immediately following completion of the Offer, CI Financial anticipates that 151,383,085 Shares will be issued and outstanding.

CI Financial Announces Meetings of Debentureholders to be Held on April 4, 2024

Retrieved on: 
Wednesday, March 20, 2024

Accordingly, the Corporation expects the Proposed Amendments to be approved at the meetings, in each case, subject to any proxies that are validly revoked or newly submitted prior to the applicable meeting.

Key Points: 
  • Accordingly, the Corporation expects the Proposed Amendments to be approved at the meetings, in each case, subject to any proxies that are validly revoked or newly submitted prior to the applicable meeting.
  • The Proposed Amendments are further described in the Joint Consent and Proxy Solicitation Statement (the “Solicitation Statement”) dated March 6, 2024, available on CI Financial’s SEDAR+ profile at www.sedarplus.ca .
  • This news release is neither a solicitation of consents or proxies nor an offer to purchase debentures or to sell any securities.
  • The Consent and Proxy Solicitation is being made solely pursuant to the Solicitation Statement.

COMPX REPORTS FOURTH QUARTER 2023 RESULTS

Retrieved on: 
Wednesday, February 28, 2024

Dallas, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today sales of $43.2 million for the fourth quarter of 2023 compared to $40.0 million in the same period of 2022.

Key Points: 
  • Dallas, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today sales of $43.2 million for the fourth quarter of 2023 compared to $40.0 million in the same period of 2022.
  • Operating income was $7.4 million in the fourth quarter of 2023 compared to $5.4 million in the same period of 2022.
  • Net income was $6.7 million, or $.54 per basic and diluted common share, for the fourth quarter of 2023 compared to $4.8 million, or $.39 per basic and diluted common share, in the same period of 2022.
  • Net sales for the year ended December 31, 2023 were $161.3 million compared to $166.6 million in the previous year.

CI Financial Announces Commencement of Consent Solicitation and Notice of Debentureholder Meetings

Retrieved on: 
Wednesday, March 6, 2024

The proposed amendments are further described in the Joint Consent and Proxy Solicitation Statement (the “Solicitation Statement”) dated March 6, 2024, a copy of which will be mailed to both the 2025 Debentureholders and 2027 Debentureholders.

Key Points: 
  • The proposed amendments are further described in the Joint Consent and Proxy Solicitation Statement (the “Solicitation Statement”) dated March 6, 2024, a copy of which will be mailed to both the 2025 Debentureholders and 2027 Debentureholders.
  • No consent fee will be payable to either the 2025 Debentureholders and 2027 Debentureholders unless both proposed amendments are approved.
  • CI retains the right to waive or modify the terms and conditions of the Consent and Proxy Solicitation at its sole discretion.
  • Questions concerning the meetings and the Consent and Proxy Solicitation, or requests for assistance in participating in the meetings or the Consent and Proxy Solicitation, should be directed to RBC by telephone at (416) 842-6311 or 1-877-381-2099 or by email at [email protected] .

CI Financial Announces Commencement of Substantial Issuer Bid

Retrieved on: 
Monday, February 26, 2024

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has commenced its previously announced substantial issuer bid (the “Offer”), pursuant to which the Corporation will offer to purchase up to 4,857,142 (the “Maximum Number of Shares”) of its outstanding common shares (the “Shares”) from holders of Shares (the “Shareholders”) for cash, at a purchase price of $17.50 per Share (the “Purchase Price”).

Key Points: 
  • CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has commenced its previously announced substantial issuer bid (the “Offer”), pursuant to which the Corporation will offer to purchase up to 4,857,142 (the “Maximum Number of Shares”) of its outstanding common shares (the “Shares”) from holders of Shares (the “Shareholders”) for cash, at a purchase price of $17.50 per Share (the “Purchase Price”).
  • The Offer would be for approximately 3.11% of the total number of issued and outstanding Shares.
  • Shares that are not taken up in connection with the Offer will be returned to Shareholders that tendered to the Offer.
  • The Corporation has further engaged NBF to act as its dealer manager and financial advisor in connection with the Offer.

The 2024 CIX Top 20 Early and Top 10 Growth Award Recipients Open the Market

Retrieved on: 
Tuesday, February 27, 2024

TORONTO, Feb. 27, 2024 /PRNewswire/ - Lisa Zarzeczny, Co-founder and Chief Executive Officer, Elevate, and her team, along with founders of the 2024 CIX Top 20 Early and Top 10 Growth award recipients, joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to celebrate CIX's selection of award winners and to open the market.

Key Points: 
  • TORONTO, Feb. 27, 2024 /PRNewswire/ - Lisa Zarzeczny, Co-founder and Chief Executive Officer, Elevate, and her team, along with founders of the 2024 CIX Top 20 Early and Top 10 Growth award recipients, joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to celebrate CIX's selection of award winners and to open the market.
  • Taking place March 26-27, 2024 in Toronto, the CIX Summit offers networking, one-one meetings, and expert advice with the highest concentration of startup execs and capital providers in Canada.
  • For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies.
  • ET and the markets will open with the sound of a siren at 9:30 a.m.

CI Financial Announces Fourth Quarter Earnings Conference Call and Webcast

Retrieved on: 
Monday, January 29, 2024

CI Financial Corp. (“CI”) (TSX: CIX) will release its financial results for the fourth quarter of fiscal 2023 on Friday, February 23, 2024.

Key Points: 
  • CI Financial Corp. (“CI”) (TSX: CIX) will release its financial results for the fourth quarter of fiscal 2023 on Friday, February 23, 2024.
  • CI will hold a conference call with analysts that day at 10:00 a.m. EST, led by Chief Executive Officer Kurt MacAlpine and Chief Financial Officer Amit Muni.
  • A live webcast of the call and slide presentation can be accessed here or through the Investor Relations section of CI’s website.
  • Alternatively, investors may listen to the discussion through the following numbers (access code: 019307):